Thwarting metastasis by breaking cancer's legs with gold rods

June 26, 2017, Georgia Institute of Technology

A dying cancer cell with stringy protrusions called filopodia, extending to the right, that help cancer cells to migrate away from their original tumors. This is not a photo of a cell treated for the Georgia Tech study. Credit: NIH-funded image of apoptotic HeLa cell by the National Center for Microscopy and Imaging Research / Thomas Deerinck / Mark Ellisman
"Your cancer has metastasized. I'm sorry," is something no one wants to hear a doctor say.

Cancer cells kill most often by crawling away from their original tumors to later re-root in vital parts of the body in a process called metastasis. Now, a research team led by the Georgia Institute of Technology has developed a new treatment to thwart it by, in a sense, breaking ' legs.

Cancer cells often cover themselves bristly leg-like protrusions that enable them to creep. The researchers have used miniscule gold rods heated gently by a laser to mangle the protrusions, according to a new study. The treatment prevented cell migration, the mechanism that leads to metastasis, in experiments on laboratory cultures (in vitro) of cancerous human cells.

The method could potentially, in the future, offer clinicians going after individual tumors a weapon to combat cancer's deadly spread at the same time. The medical field is currently less than well-equipped to stop metastasis.

"If cancer stays in a tumor in one place, you can get to it, and it's not so likely to kill the patient, but when it spreads around the body, that's what really makes it deadly," said lead researcher Mostafa El-Sayed, Julius Brown Chair and Regents Professor at Georgia Tech's School of Chemistry and Biochemistry.

The treatment can also easily kill cancer cells, but in this experiment, it was vital to specifically show that it greatly shows cell migration.

Halting cancer softly

The experimental treatment also spared , in these and in prior experiments, making the method potentially much less taxing on patients than commonly used chemotherapy. In past tests in animal models, the researchers have uncovered no toxic side effects from the gold used in the treatment, and have found no observable damage to healthy tissue from the low-energy laser.

And they did not see recurrence of the treated cancer.

"The method appears to be very effective as a locally administered treatment that also protects the body from cancer's spread away from the treated tumors, and it is also very mild, so it can be applied many times over if needed," El-Sayed said.

El-Sayed, co-lead author Ronghu Wu, and first authors Yue Wu and Moustafa Ali published the results of their current in vitro experiments, a new development in photothermal gold nanorod therapy, on June 26, 2017, in the Proceedings of the National Academy of Sciences. Research was funded by the National Science Foundation and the National Institutes of Health.

How it works: Icky legs

To understand how the treatment works, let's take a close-up look at a cell, and some things that happen to it in .

Many people think of cells as watery balloons—fluid encased in a membrane sheath with organelles floating around inside. But that picture is incomplete. Cells have support grids called cytoskeletons that give them form and that have functions.

The cytoskeletons also form bristly protrusions called filopodia, which extend out from a weave of fibers called lamellipodia that are on the cell's fringes. The protrusions normally help healthy cells shift their location in the tissue that they are part of.

But in malignant cancer, normally healthy cell functions often lunge into destructive overdrive. Lamellipodia and filopodia are wildly overproduced.

"All these lamellipodia and filopodia give the cancer cells legs," said Yue Wu, a graduate student in bioanalytical chemistry. "The metastasis requires those protrusions, so the cells can travel."

A cancer cell lab culture after treatment with gold nanorods and infrared light, denaturating lamellipodia and filopodia to halt cell migration, a key factor in metastasis. Credit: Georgia Tech / El-Sayed group
How it works: Sticky rods

The thwart the protrusions in two ways. The rods are comprised of a small collection of gold atoms - nano refers to something being just billionths of meters (or feet) in size.

First, El-Sayed's nanorods are introduced locally, where they encumber the leggy protrusions on . The rods are coated with molecules (RGD-peptides) that make them stick specifically to a type of cell protein called integrin.

"The targeted nanorods tied up the integrin and blocked its functions, so it could not keep guiding the cytoskeleton to overproduce lamellipodia and filopodia," said Yan Tang, a postdoctoral assistant in computational biology who worked on the study. The binding of the integrin alone slowed down the migration of .

But healthy cells were not targeted. "There are certain, specific integrins that are overproduced in cancerous cells," said Moustafa Ali, one of the study's first authors. "And you don't find them so much in healthy cells."

How it works: Gentle laser heating

In the second phase, researchers hit the gold nanoparticles with a low-energy laser with near-infrared (NIR) light. It appeard to bring the migration of the cancer cells to a halt.

"The light was not absorbed by the cells, but the gold nanorods absorbed it, and as a result, they heated up and partially melted cancer cells they are connected with, mangling lamellipodia and filopodia," Ali said. "It didn't kill all the cells, not in this experiment. If we killed them, we would not have been able to observe whether we stopped them from migrating or not."

If desired, the treatment can also be applied to kill the cells.

Early experiments in animal models in vivo with hotter lasers didn't work as well. "That caused inflammation, which made it possible to heat one time only," Ali said. "As a result, that high temperature would wipe out many cancer cells, but not all of them. Some hidden ones might have survived, and also still been able to migrate."

"This gentle laser didn't burn the skin or damage tissue, so it could be dosed multiple times and more thoroughly stop the cancer from being able to travel," said researcher Ronghu Wu.

Medical possibilities

The researchers presently envision treating head, neck, breast, and skin cancers with direct, local injections, and the low-power near-infrared laser they use can hit gold nanorods 2-3 centimeters (a bit under or over an inch) deep inside tissue. "But it could go as deep as 4-5 centimeters," Ali said.

Deeper tumors could conceivably be treated with deeper injections of nanorods. "Then you'd need to go in with a fiber optic or endoscopic laser," El-Sayed said. Injecting the nanorods directly into the bloodstream as a broad treatment would not currently be a viable option.

El-Sayed's group has previously published in vivo studies in the Proceedings of the National Academy of Sciences together with Emory University School of Medicine on promising treatments on animal models. That study showed no observable toxicity from the gold in mice 15 months after .

"A lot of it ended up in the liver and spleen," El-Sayed said. "But the functions of these organs appeared intact upon examination, and treated mice were alive and healthy over a year later."

Presidential honors

Mostafa El-Sayed is one of the world's most highly decorated and cited living chemists, and a pioneer of nanoscience and technology. Among his many recognitions are the President's National Medal of Science, awarded by President George W. Bush, and the Priestley Medal, the American Chemical Society's highest honor. President Barack H. Obama appointed El-Sayed to the President's National Medal of Science Committee. El-Sayed also participated in the nomination of chemistry Nobel Laureate Ahmed Zewail.

El-Sayed is known throughout physical chemistry for "El-Sayed's Rule," which handles complexities of electron spin orbits, and which has found a lasting place in photochemistry textbooks. After losing his wife to in 2005, El-Sayed dedicated his knowledge and research to ending the scourge.

Explore further: Nanorods show benefits cancer treatment

More information: Moustafa R. K. Ali el al., "Targeting cancer cell integrins using gold nanorods in photothermal therapy inhibits migration through affecting cytoskeletal proteins," PNAS (2017).

Related Stories

Nanorods show benefits cancer treatment

March 14, 2006
Researchers at the Georgia Institute of Technology and the University of California, San Francisco, have found an even more effective and safer way to detect and kill cancer cells. By changing the shapes of gold nanospheres ...

Video: An interview with 2016 Priestley medalist Mostafa El-Sayed

December 19, 2016
It's difficult to sum up Mostafa El-Sayed's nearly 60-year career as a chemist in just a few sentences. He uses lasers and other tools to better understand the properties and behavior of molecules and the nanoscale world. ...

Using Gold Nanoparticles to Hit Cancer Where It Hurts

February 15, 2010
( -- Taking gold nanoparticles to the cancer cell and hitting them with a laser has been shown to be a promising tool in fighting cancer, but what about cancers that occur in places where a laser light can’t ...

Gold nanorods hitch ride on immune cells that target breast tumors

August 17, 2012
One of the challenges in treating cancer, whether using nanotechnology or not, is that tumors can often be inaccessible to the therapies designed to kill them. Mostafa El-Sayed, of the Georgia Institute of Technology, and ...

Gold Nanoparticles May Simplify Cancer Detection

May 9, 2005
Binding gold nanoparticles to a specific antibody for cancer cells could make cancer detection much easier, suggests research at the Georgia Institute of Technology and the University of California at San Francisco (UCSF). ...

Gentle cancer treatment using nanoparticles works

August 3, 2016
Cancer treatments based on laser irridation of tiny nanoparticles that are injected directly into the cancer tumor are working and can destroy the cancer from within. Researchers from the Niels Bohr Institute and the Faculty ...

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.